We sit down with you and build your perfect lead list. Book a call with founders.

Granza Bio Analysis

What is Granza Bio?

Granza Bio specializes in synthetic recreation of immune system attack particles. Their precision shell technology enables targeted delivery of therapeutic cargo to specific tissues. This innovative approach has the potential to transform treatment for diseases like cancer and autoimmunity.

HQ Country
San Francisco, United States
Employees
1-10
Founded
2023
Industry
Biotech, HealthTech

Product Features & Capabilities

  • Precision shell technology for delivering attack particles
  • Delivery of RNAs, proteins, and genetic modifiers
  • Targeted delivery to hard-to-reach organs
  • Overcoming immunological activation during delivery
  • Autonomous operation independent of immune cells.

How much Granza Bio raised

Funding Round - N/A

Amount - N/A

Stage - N/A

Date - N/A

Investors - N/A

Financial Overview

Funding Round
Amount
Stage
Date
Investors
Want to research more data points on Granza Bio?
Start with Extruct